Steroid Hormone Agonists and Antagonists in the Treatment of Cancer
- 1 January 1992
- journal article
- research article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 10 (1) , 27-41
- https://doi.org/10.3109/07357909209032786
Abstract
(1992). Steroid Hormone Agonists and Antagonists in the Treatment of Cancer. Cancer Investigation: Vol. 10, No. 1, pp. 27-41. doi: 10.3109/07357909209032786Keywords
This publication has 100 references indexed in Scilit:
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- Estradiol-stimulated growth of MCF-7 tumors implanted in athymic mice: A model to study the tumoristatic action of tamoxifenJournal of Steroid Biochemistry, 1988
- Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast CancerNew England Journal of Medicine, 1988
- Cloning, structure and expression of a cDNA encoding the human androgen receptorBiochemical and Biophysical Research Communications, 1988
- A human retinoic acid receptor which belongs to the family of nuclear receptorsNature, 1987
- Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-ANature, 1986
- MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGFBiochemical and Biophysical Research Communications, 1985
- Immunochemical studies of estrogen receptorsJournal of Steroid Biochemistry, 1984
- Autocrine Secretion and Malignant Transformation of CellsNew England Journal of Medicine, 1980